Skip to main content
. 2019 Mar 5;34(1):761–772. doi: 10.1080/14756366.2019.1584622

Table 1.

In vitro T. gondii growth inhibition and cytotoxicity on HeLa cells.

Compounds R IC50a in HeLa cells (μM) IC50b in T. gondii (μM) SIc
1a -H >1000 >1000
1b 2-F 419.6 711.9 0.59
1c 3-F >1000 >1000
1d 4-F >1000 >1000
1e 2-Cl 466.1 239.6 1.95
1f 3,4-Cl 408.0 462.1 0.88
1g 2-Br 240.4 301.7 0.80
1h 2-I 230.4 273.8 0.84
1i 2-OCH3 >1000 >1000
1j 3,4,5-OCH3 353.7 301.3 1.17
2a -H 836.8 >1000
2b 4-Cl 328.7 >1000
2c 4-OCH3 >1000 >1000
2d 4-CH3 >1000 >1000
2e 3,4-Cl >1000 >1000
3a -H 101.5 88.0 1.15
3b 4-Cl 2.4 6.7 0.36
3c 4-F 88.2 61.4 1.44
3d 4-NO2 226.7 128.0 1.77
3e 4-OCH3 78.2 116.5 0.67
Spiramycin 189.0 262.2 0.72
Ursolic Acid 44.8 72.2 0.62
a

IC50 in HeLa cells: Median toxicity dose, a measure of cytotoxicity against host cells.

b

IC50 in T. gondii: Median inhibitory concentration, a measure of tachyzoite inhibition.

c

SI: Selectivity index, a measure of efficacy, calculated by IC50 in HeLa cells/IC50 in T. gondii.